Lab-made ovarian implants to restore hormones and protect bone health in women
Sustained regulation of hypothalamus-pituitary-ovary hormones with tissue-engineered ovarian constructs as a treatment for osteoporosis in females
Testing whether implanting lab-grown ovarian tissue can restore hormone balance and reduce bone loss in women with menopause or ovarian failure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miami University Oxford NIH-funded |
| Lab location | 1 site (Oxford, United States) |
| Project ID | NIH-11332471 on NIH RePORTER |
What this research studies
Researchers are developing tissue-engineered ovarian constructs that release natural ovarian hormones and aim to re-establish the hypothalamus‑pituitary‑ovary hormone cycle. They will test these implants in the lab and in animal models to measure sustained hormone release and effects on bone density and fracture risk. The goal is to create a long-lasting, physiologic hormone source that protects bone while using lower systemic hormone doses than traditional pills. If preclinical results are promising, the team intends to move toward studies that could include people.
Who could benefit from this research
Good fit: Women who have lost ovarian hormone production due to menopause or surgical ovarian failure and who are at increased risk for osteoporosis are the likely candidates.
Not a fit: People with a history of hormone-sensitive cancers, major cardiovascular disease, or those unwilling to consider an implant procedure may not be helped by this approach.
Why it matters
Potential benefit: Could provide a longer-lasting, more natural hormone replacement that lowers fracture risk while avoiding some risks seen with standard hormone pills.
How similar studies have performed: Related tissue-engineering approaches have shown promise in animal studies, but human testing of ovarian implants is still largely unproven.
Where this research is happening
Oxford, United States
- Miami University Oxford — Oxford, United States (Active)
Researchers
- Principal investigator: Saul, Justin — Miami University Oxford
- Study coordinator: Saul, Justin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.